The R&D response to the SARS-CoV-2 outbreak has been massive, promoted by unprecedented funding to support innovative solutions to fight the COVID-19 pandemic.
There is no discussion there is an increasing pressure over healthcare professionals. Recent times have just increased that feeling, and there may be some explanations to it. On the one side, the general public is increasing its requirements to the healthcare system, possibly poised by the press pressure of the apparent exciting results on healthcare. Not to say that it is ever more difficult to deliver significant improvements in healthcare, as major breakthroughs seem to have gone by. On the other side the financial pressure, where budgets have been cut, access is reduced or restricted and increasing scrutiny is posed on every euro spent.
En un marc d’una creixent pressió sobre el sector sanitari, cal plantejar solucions més enllà del preu i dels anomenats “Acords de Risc Compartit”. La legislació vigent ofereix camins per a buscar noves alternatives, que pretenen fomentar la participació de tots els actors del sistema.